US FDA approves Mainstay Medical's ReActiv8 product
Dublin-headquartered medical device company Mainstay Medical said today that the US Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application for its ReActiv8 product.
Business
• 22 Jun 20
